Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bites and Stings × Androgen Receptor Antagonists × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1 Bites and Stings 1

Interventions

pembrolizumab 2 enzalutamide 2 abiraterone 2 Immune Checkpoint Inhibitors 2 Cytochrome P-450 Enzyme System 2 durvalumab 1 dostarlimab 1 cemiplimab 1 blinatumomab 1 atezolizumab 1 Surgical Instruments 1 Hydroxyurea 1 Etoposide 1 Etanercept 1 Carboplatin 1 Androgen Receptor Antagonists 1 AMG 757 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04631601 2025-10-07

Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)

Amgen

Phase 1/2 Terminated

Bites and Stings

Data powered by HemOnc (CC BY 4.0) Colophon ⚡